Evidence map›Paper›PMID 39945554›Full record

ReviewACS applied bio materials2025

Enzyme-Embedded Biodegradable Plastic for Sustainable Applications: Advances, Challenges, and Perspectives.

Shengwei Sun

Abstract readReview
In one paragraph

Review in ACS applied bio materials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. EngineeringiScience · 2026
    Article
  3. Article
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Shengwei SunSchool of Engineering Sciences in Chemistry, Biotechnology and Health, Department of Fibre and Polymer Technology, KTH Royal Institute of Technology, 10044 Stockholm, Sweden.ORCID 0000-0002-2757-9273

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Global plastic production is increasing yearly, with packaging materials and disposable plastics accounting for a sizable portion of the total. Despite its apparent advantages, the resulting plastic waste accumulates in landfills and oceans, causing severe environmental and public health issues. Shifting from conventional plastics to biodegradable plastics (BPs) is increasingly being proposed as an efficient management of end-of-life plastics. While several BPs such as poly(lactic acid), poly(ε-caprolactone), and poly(hydroxyalkanoates) have been widely used, their biodegradation rates often do not meet the anticipated level under home-compost or other certain environments (e.g., soil, marine). Recently, enzyme-embedded BPs have emerged as an outstanding alternative to currently used synthetic plastics. It achieves rapid degradation and compostability by introducing a specific enzyme into the biodegradable polymer. In this context, this review aims to summarize the recent advances in the development of such superior biomaterials. It identifies and prioritizes the critical success factors required for the production of enzyme-embedded BPs. The review also discusses several challenges in the development and application of these innovative polymer materials.

Indexed as

Biocompatible MaterialsBiodegradable PlasticsEnzymesEnzymes, ImmobilizedBiodegradation, EnvironmentalBiocompatible MaterialsBiodegradable PlasticsEnzymesEnzymes, Immobilizedbiodegradable plasticsbiodegradationchallengesenzymeenzyme-embedded BPs

Identifiers

PMID39945554
PMCPMC11920951

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.